About 15 results found for searched term "RF9" (0.051 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2057 | Dexrazoxane hydrochloride | Topoisomerase |
| Cardioxane, ICRF-187, NSC169780, Zinecard，DXZ | ||
| Dexrazoxane HCl (ICRF-187, ADR-529, DXZ) is an iron chelator that can be used to prevent DOX-induced cardiotoxicity. | ||
| M2705 | Florfenicol | Antibiotic |
| (-)-Florfenicol; SCH-25298 | ||
| Florfenicol is a fluorinated synthetic analog of thiamphenicol with broad-spectrum, primarily bacteriostatic activity. | ||
| M3058 | Terfenadine | Potassium Channel |
| (±)-Terfenadine; MDL-991 | ||
| Terfenadine is an antihistamine compound that is normally fully metabolized in the liver by the cytochrome P450 CYP3A4 subtype enzyme into the active form fexofenadine. | ||
| M3539 | Verteporfin (CL 318952) | YAP |
| CL 318952; BPD-MA | ||
| Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin (CL 318952) is a YAP inhibitor that disrupts YAP-TEAD interactions, and it is also an inhibitor of autophagy. | ||
| M7191 | RF9 | Neuropeptide Receptor |
| RF-9; RF 9 | ||
| RF9 is a selective NPFF receptor antagonist (Ki values are 58 and 75 nM at hNPFF1 and hNPFF2 receptors respectively). | ||
| M7746 | Dexrazoxane | Others |
| ICRF187; NSC169780；DXZ | ||
| Dexrazoxane (ICRF-187, ADR-529, DXZ) is an iron chelator that can be used to prevent DOX-induced cardiotoxicity. | ||
| M9496 | Balaglitazone | PPAR |
| DRF-2593; NN-2344; NNC-610645 | ||
| Balaglitazone is an agonist of peroxisome proliferator-activated receptor (PPAR) γ, with an EC50 of 1.351 μM for human PPARγ. | ||
| M15052 | Recombinant Human 4-1BB Ligand/TNFSF (E.coli,C-6His) | Cytokines and Growth Factors |
| Tumor necrosis factor ligand superfamily member 9; | ||
| The recombinant human 4-1BB ligand was produced by the escherichia coli expression system, and the target gene encoding ARG71-GLU254 was expressed at the C-terminal as 6His marker. Accession # : P41273. | ||
| M14824 | GRF (1-29) amide (rat) | Peptides |
| rGHRH(1-29)NH2 | ||
| GRF (1-29) amide (rat) is a synthetic peptide which can stimulate the growth hormone (GH) secretion. | ||
| M41619 | ICRF-196 | Topoisomerase |
| ICRF-196 is an racemic mixture of the (S,S)- and (R,R)-isomers of ICRF-193. | ||
| M41622 | ICRF-193 | Topoisomerase |
| ICRF-193 is an TopoII inhibitor. | ||
| M51468 | (D-Ala2)-GRF (1-29) amide (human) | Others |
| (D-Ala2)-GRF (1-29) amide (human) is a superagonist of GRF, exhibiting extremely high GH-releasing activity about 50 times that of GRF (1-29) in both pigs and rats. | ||
| M51663 | [Ac-Tyr1, D-Phe2]GRF 1-29, amide (human) | Others |
| [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist. | ||
| M54012 | α-Helical CRF(9-41) | CRFR |
| α-Helical CRF(9-41) is a competitive CRF2 receptor antagonist with KB of ~100 nM. | ||
| M54050 | Acetyl-(D-Arg2)-GRF (1-29) amide (human) | Others |
| Acetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
